Business · 06/11/2023
FDA Clears Path for FORADIL Inhalation Powder Approval
The FDA has determined that FORADIL inhalation powder, 0.012 mg/inh, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of formoterol fumarate inhalation powder through abbreviated new drug applications.